
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
MiRNA-mediated EMT and CSCs in cancer chemoresistance
Bing Dong, Shiyu Li, Shuangli Zhu, et al.
Experimental Hematology and Oncology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 65
Bing Dong, Shiyu Li, Shuangli Zhu, et al.
Experimental Hematology and Oncology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 65
Showing 1-25 of 65 citing articles:
Macrophages in immunoregulation and therapeutics
Shanze Chen, Abdullah F. U. H. Saeed, Quan Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 750
Shanze Chen, Abdullah F. U. H. Saeed, Quan Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 750
Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy
Yangfu Jiang, Hongying Zhang, Jiao Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 260
Yangfu Jiang, Hongying Zhang, Jiao Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 260
Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential
Zhengjun Lin, Yanlin Wu, Yiting Xu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 167
Zhengjun Lin, Yanlin Wu, Yiting Xu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 167
Breast cancer heterogeneity and its implication in personalized precision therapy
Liantao Guo, Deguang Kong, Jianhua Liu, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 140
Liantao Guo, Deguang Kong, Jianhua Liu, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 140
The Role of MicroRNAs in Chemoresistance
Farbod Bahreini, Nima Rezaei
Springer eBooks (2023), pp. 1-39
Closed Access | Times Cited: 95
Farbod Bahreini, Nima Rezaei
Springer eBooks (2023), pp. 1-39
Closed Access | Times Cited: 95
Focal adhesion kinase: from biological functions to therapeutic strategies
Ximin Tan, Yuheng Yan, Bin Song, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 54
Ximin Tan, Yuheng Yan, Bin Song, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 54
Establishment and characterization of three gemcitabine-resistant human intrahepatic cholangiocarcinoma cell lines
Jian‐Dong Li, Yanxin Hu, Jiayao Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Jian‐Dong Li, Yanxin Hu, Jiayao Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Roles of tumor-associated macrophages in tumor progression: implications on therapeutic strategies
Shuangli Zhu, Ming Yi, Yuze Wu, et al.
Experimental Hematology and Oncology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 99
Shuangli Zhu, Ming Yi, Yuze Wu, et al.
Experimental Hematology and Oncology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 99
A role for partial epithelial-to-mesenchymal transition in enabling stemness in homeostasis and cancer
Jeroen Verstappe, Geert Berx
Seminars in Cancer Biology (2023) Vol. 90, pp. 15-28
Open Access | Times Cited: 40
Jeroen Verstappe, Geert Berx
Seminars in Cancer Biology (2023) Vol. 90, pp. 15-28
Open Access | Times Cited: 40
Salivary Exosomal miRNA-1307-5p Predicts Disease Aggressiveness and Poor Prognosis in Oral Squamous Cell Carcinoma Patients
Aditi Patel, Shanaya Patel, Parina Patel, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10639-10639
Open Access | Times Cited: 39
Aditi Patel, Shanaya Patel, Parina Patel, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10639-10639
Open Access | Times Cited: 39
Exosomes in Cancer Progression and Therapy Resistance: Molecular Insights and Therapeutic Opportunities
Madita Wandrey, Jadwiga Jabłońska, Roland H. Stauber, et al.
Life (2023) Vol. 13, Iss. 10, pp. 2033-2033
Open Access | Times Cited: 25
Madita Wandrey, Jadwiga Jabłońska, Roland H. Stauber, et al.
Life (2023) Vol. 13, Iss. 10, pp. 2033-2033
Open Access | Times Cited: 25
Myeloid-like tumor hybrid cells in bone marrow promote progression of prostate cancer bone metastasis
Xinyu Ye, Xin Huang, Xing Fu, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 23
Xinyu Ye, Xin Huang, Xing Fu, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 23
Rabdosia rubescens (Hemsl.) H. Hara: A Potent Anti-Tumor Herbal Remedy - Botany, Phytochemistry, and Clinical Breakthroughs
Shiyong Gao, Li JianWen, Weiya Wang, et al.
Journal of Ethnopharmacology (2024) Vol. 340, pp. 119200-119200
Closed Access | Times Cited: 9
Shiyong Gao, Li JianWen, Weiya Wang, et al.
Journal of Ethnopharmacology (2024) Vol. 340, pp. 119200-119200
Closed Access | Times Cited: 9
Valproic Acid and Breast Cancer: State of the Art in 2021
Anna Wawruszak, Marta Hałasa, Estera Okoń, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3409-3409
Open Access | Times Cited: 53
Anna Wawruszak, Marta Hałasa, Estera Okoń, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3409-3409
Open Access | Times Cited: 53
Circular RNA circHERC4 as a novel oncogenic driver to promote tumor metastasis via the miR-556-5p/CTBP2/E-cadherin axis in colorectal cancer
Jiehua He, Ziqiang Chu, Lai Wei, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 50
Jiehua He, Ziqiang Chu, Lai Wei, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 50
Overview of Evidence-Based Chemotherapy for Oral Cancer: Focus on Drug Resistance Related to the Epithelial-Mesenchymal Transition
Jingjing Sha, Yunpeng Bai, Huy Ngo, et al.
Biomolecules (2021) Vol. 11, Iss. 6, pp. 893-893
Open Access | Times Cited: 45
Jingjing Sha, Yunpeng Bai, Huy Ngo, et al.
Biomolecules (2021) Vol. 11, Iss. 6, pp. 893-893
Open Access | Times Cited: 45
Roles of Microvesicles in Tumor Progression and Clinical Applications
Shuangli Zhu, Shiyu Li, Ming Yi, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 7071-7090
Open Access | Times Cited: 45
Shuangli Zhu, Shiyu Li, Ming Yi, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 7071-7090
Open Access | Times Cited: 45
The regulation of PBXs and their emerging role in cancer
Ying Liu, Xiang Ao, Xuehao Zhou, et al.
Journal of Cellular and Molecular Medicine (2022) Vol. 26, Iss. 5, pp. 1363-1379
Open Access | Times Cited: 38
Ying Liu, Xiang Ao, Xuehao Zhou, et al.
Journal of Cellular and Molecular Medicine (2022) Vol. 26, Iss. 5, pp. 1363-1379
Open Access | Times Cited: 38
Epigenetic programing of cancer stemness by transcription factors-non-coding RNAs interactions
Reem Khaled M.E. Alsayed, Khalid Sultan A. M. Sheikhan, Majid Alam, et al.
Seminars in Cancer Biology (2023) Vol. 92, pp. 74-83
Open Access | Times Cited: 20
Reem Khaled M.E. Alsayed, Khalid Sultan A. M. Sheikhan, Majid Alam, et al.
Seminars in Cancer Biology (2023) Vol. 92, pp. 74-83
Open Access | Times Cited: 20
The role of gut microbiota and metabolites in cancer chemotherapy
Shiyu Li, Shuangli Zhu, Jun Yu
Journal of Advanced Research (2023) Vol. 64, pp. 223-235
Open Access | Times Cited: 19
Shiyu Li, Shuangli Zhu, Jun Yu
Journal of Advanced Research (2023) Vol. 64, pp. 223-235
Open Access | Times Cited: 19
LncRNA FOXD1-AS1 regulates pancreatic cancer stem cell properties and 5-FU resistance by regulating the miR-570-3p/SPP1 axis as a ceRNA
Liu Ouyang, Minmin Sun, Ping-sheng Zhou, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Liu Ouyang, Minmin Sun, Ping-sheng Zhou, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
ARID3A enhances chemoresistance of pancreatic cancer via inhibiting PTEN-induced ferroptosis
Xiaoqi Mao, Jin Xu, Mingming Xiao, et al.
Redox Biology (2024) Vol. 73, pp. 103200-103200
Open Access | Times Cited: 7
Xiaoqi Mao, Jin Xu, Mingming Xiao, et al.
Redox Biology (2024) Vol. 73, pp. 103200-103200
Open Access | Times Cited: 7
Tanshinone IIA attenuates the stemness of breast cancer cells via targeting the miR-125b/STARD13 axis
Xiaoman Li, Qi Jia, Yinyin Zhou, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 23
Xiaoman Li, Qi Jia, Yinyin Zhou, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 23
Exploiting E3 ubiquitin ligases to reeducate the tumor microenvironment for cancer therapy
Xian-Miao Li, Zhenyu Zhao, Yu Xiao, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 14
Xian-Miao Li, Zhenyu Zhao, Yu Xiao, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 14
Role of Exosomes in Cancer and Aptamer-Modified Exosomes as a Promising Platform for Cancer Targeted Therapy
Yating Wu, Yue Cao, Li Chen, et al.
Biological Procedures Online (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 5
Yating Wu, Yue Cao, Li Chen, et al.
Biological Procedures Online (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 5